Specific characteristics and current diagnostic and treatment modalities performance of super refractory status

George Briassoulis1, Chrysavgi Stefanogianni1, Ioannis Zaganas2

  • 1Pediatric Intensive Care Unit, University Hospital, School of Medicine, University of Crete, Heraklion, Crete, Greece.

Insights

Super-refractory status epilepticus (SRSE) in children leads to poor outcomes and prolonged hospital stays. Early diagnosis and treatments like immunotherapy or ketogenic diets show promise for better seizure control and functional recovery.

Area of Science:

  • Pediatric intensive care
  • Neurology
  • Epileptology

Background:

  • Super-refractory status epilepticus (SRSE) presents significant challenges in pediatric intensive care units (PICUs), associated with high morbidity and mortality.
  • Understanding the clinical spectrum and outcomes of SRSE compared to status epilepticus (SE) and refractory SE (RSE) is crucial for improving patient management.

Purpose of the Study:

  • To explore the clinical characteristics, treatment modalities, and outcomes of pediatric patients with SRSE admitted to a PICU.
  • To compare the performance of diagnostic and treatment approaches in SRSE against SE and RSE cohorts.
  • To identify predictors of poor outcomes in pediatric SRSE patients.

Main Methods:

  • Retrospective analysis of 86 pediatric patients with convulsive SE admitted to a PICU between 2009 and 2019.
  • Classification of patients into SE, RSE, and SRSE groups, with identification of New-onset refractory status epilepticus (NORSE) and Febrile infection-related epilepsy syndrome (FIRES).
  • Evaluation of functional outcomes using the modified Rankin scale and analysis of diagnostic and treatment modalities.

Main Results:

  • SRSE patients (n=20) experienced longer mechanical ventilation, hospital stays, and poorer outcomes compared to SE (n=13) and RSE (n=53) patients.
  • High prevalence of NORSE (n=13) and FIRES (n=9) was associated with SRSE. Abnormal MRI findings and epilepsy-related pathogenic variants via whole-exome sequencing (WES) were more common in SRSE.
  • Plasmapheresis and ketogenic diet were more effective for seizure control in SRSE than intravenous immunoglobulins or steroid pulses. SRSE and diagnosis were significant predictors of poor outcome.

Conclusions:

  • Pediatric SRSE is linked to substantial functional decline and morbidity.
  • WES analysis can identify epilepsy-related variants, and early aggressive immunotherapy or ketogenic diets may improve outcomes.
  • Further multicenter studies are required to develop robust outcome prediction models for pediatric SRSE.
Abstract